The Cisco and Deutsche Telekom-backed interactive video advertising software provider will acquire an NYSE spot after the deal, valuing it at a $1.3bn pro-forma equity valuation.

CapitalG is in line to score an exit from the language learning app developer, which was valued at $2.4bn in its last funding round.

The Stanford spinout has gone public following a $238m IPO, after revealing that the university was also among the series B investors.

Karolinska Development-backed Biosergen has begun trading on the Nasdaq First Growth Market, having already undertaken a $5.9m offering earlier this month.

The Asahi Kasei and Shenzhen Hepalink-backed microbial detection system provider has amassed over $340m of funding before filing for an initial public offering.

The cancer drug developer is set to float on the Nasdaq Global Select Market, presenting an opportunity for strategic investors Pharmaron, Celgene, Amgen and Merck & Co to exit.

University of Oxford and OSI are set to exit the medical diagnostics software provider in a flotation with a $75m placeholder target.

The Lenovo and Tencent-backed digital grocer’s shares fell almost 26% in price after it priced its shares at the foot of their range.

SoftBank, Hearst and NBCUniversal-backed digital media company will get a Nasdaq listing through the deal, valuing it just below its last funding round five years ago.

Blue Venture Fund is set to exit the medical diagnostics software provider in a flotation with a $75m placeholder target.